Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • UMC vs GSK✓SelectedUSD · GSKUMC vs GSK performance historyLatest closeAs of-6.88%11/16
Stock and ETF performance explorer

UMC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+137.2%
GSK return
+206.8%
Excess return
-69.6%
Maximum drawdown
-89.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.9%-0.1%-6.8%-6.8%
7D-3.7%-1.3%-2.4%-3.2%
30D-27.6%+2.7%-30.4%-28.7%
3M-25.1%+2.7%-27.8%-26.5%
6M-15.2%+3.3%-18.5%-18.1%
YTD+85.7%+6.5%+79.2%+74.9%
1Y+104.4%+10.7%+93.7%+88.7%
3Y+115.5%+64.4%+51.2%+56.3%
5Y+66.2%+46.7%+19.5%+24.4%
10Y+1,185.4%+109.4%+1,076.0%+643.1%
All+137.2%+206.8%-69.6%-1.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling